1-4 of 4
T Zimmerman
Close
Sort by
Journal Articles

Secondary Hematologic Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma Are Associated with a Distinct Mutational Profile

Ariel Kleman, MD, Arun K Singavi, MD MS, Lauren Pommert, MDMS, Michael T Zimmerman, PhD, Wendy Demos, Angela Mathison, PhD, Sridhar Rao, MDPhD, Karen-Sue Carlson, MDPhD, Parameswaran Hari, MD MRCP
Journal: Blood
Blood (2020) 136 (Supplement 1): 28.
https://doi.org/10.1182/blood-2020-142410
Published: 2020
Journal Articles

Do Leucopenia Rates Change After Widespread Folic Acid Fortification in Randomized Controlled Trials of Breast Cancer Chemotherapy?

Collin T Zimmerman, MD, William Read
Journal: Blood
Blood (2009) 114 (22): 4741.
https://doi.org/10.1182/blood.V114.22.4741.4741
Published: 2009
Journal Articles

Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer

SF Williams, WJ Lee, JG Bender, T Zimmerman, P Swinney, M Blake, J Carreon, M Schilling, S Smith, DE Williams, F Oldham, D Van Epps
Journal: Blood
Blood (1996) 87 (5): 1687–1691.
https://doi.org/10.1182/blood.V87.5.1687.1687
Published: 1996
Journal Articles

Acquired von Willebrand's disease in the myeloproliferative syndrome

U Budde, G Schaefer, N Mueller, H Egli, J Dent, Z Ruggeri, T Zimmerman
Journal: Blood
Blood (1984) 64 (5): 981–985.
https://doi.org/10.1182/blood.V64.5.981.981
Published: 1984